What is Respiratory Syncytial Virus (RSV)?

Respiratory syncytial virus (RSV) is a common respiratory illness that affects the lungs and airways. Some groups including infants, young children, and older adults are more likely to develop severe illness from RSV infection. Immunization is available to prevent serious illness and hospitalization caused by the virus.

RSV Vaccines

Two vaccines are available to protect older adults from RSV (Arexvy and Abrysvo).

Arexvy and Abrysvo are approved for use in adults 60 years of age and older
Abrysvo is approved for use in pregnant people who are 32 to 36 weeks pregnant to protect infants from RSV

RSV immunization for infants and children

There is currently no RSV vaccine for infants and children. An antibody-containing product (Beyfortus) provides immediate protection against RSV and may be given to newborns and select groups of young children.

Additional information

For more information about RSV, talk to your health care provider, a public health nurse or review these Ministry of Health resources:

Eligible individuals who do not have a family doctor or access to a health care provider can book an RSV immunization appointment by calling their local NWHU office location.